NCT02112136

Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD

Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in Autosomal Dominant Polycystic Kidney Disease (ADPKD): The GeneQuest Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,450 (actual)
• Sponsor: University Hospital, Brest · Academic / Other
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to identify families with ADPKD , characterize the phenotype and screen for mutations in known genes (PKD1 and PKD2, and then HNF1b and UMOD in PKD1 PKD2 negative carriers). Genome wide analysis will be performed in families without mutations identified.

Detailed description

* Inclusion of ADPKD patients in 20 different centers of Nephrology in the Western part of France * Characterization of the Phenotype * Collect DNA sample * Analysis of PKD1 and PKD2 genes first * Analysis of HNFIb and UMOD for PKD1 and PKD2 negative patients * Recruitment of affected and non-affected relatives of PKD1 and PKD2 negative ADPKD patients * Identify new genes involved in ADPKD using exome sequencing in PKD1 and PKD2 negative pedigrees

Conditions

• Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

Type	Name	Description
OTHER	Blood Collection	Phenotype and Genotype Analysis, Biological Analysis

Timeline

• Start date: 2014-12-12
• Primary completion: 2020-12-12
• Completion: 2020-12-12
• First posted: 2014-04-11
• Last updated: 2021-03-24

Locations

25 sites across 1 country: France